NEURONES: 11.1% orga
NEURONES: 11.1% organic growth in 2023
February 07, 2024 11:40 ET | NEURONES
PRESS INFORMATIONHeading: 2023 annual revenues        Nanterre, February 7, 2024 (after trading) 11.1% organic growth in 2023 (being audited, in € millions)20222023Growthof which...
NEURONES : + 11,1% d
NEURONES : + 11,1% de croissance organique en 2023
February 07, 2024 11:40 ET | NEURONES
INFORMATION PRESSERubrique : C.A. annuel 2023        Nanterre, le 7 février 2024 (après Bourse) + 11,1% de croissance organique en 2023 (en cours d’audit, en M€)20222023Croissancedont...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, THE FIRST FILING FIRM, Encourages Paycom Software, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – PAYC
November 19, 2023 13:20 ET | The Rosen Law Firm PA
NEW YORK, Nov. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
July 30, 2021 - ROSEN LOGO.jpg
NATIONALLY RANKED ROSEN LAW FIRM Encourages Paycom Software, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – PAYC
November 16, 2023 13:55 ET | The Rosen Law Firm PA
NEW YORK, Nov. 16, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
Osisko publie ses ré
Osisko publie ses résultats du troisième trimestre de 2023
November 08, 2023 17:00 ET | Redevances Aurifères Osisko Ltée
MONTRÉAL, 08 nov. 2023 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (la « Société » ou « Osisko ») (TSX et NYSE : OR) annonce aujourd’hui ses résultats financiers consolidés pour le...
20180109-ogr_200.jpg
Osisko Reports Q3 2023 Results
November 08, 2023 17:00 ET | Osisko Gold Royalties Ltd.
MONTREAL, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) today announced its consolidated financial results for the third quarter of...
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update
November 08, 2023 16:11 ET | Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results
NEURONES: Organic gr
NEURONES: Organic growth up 12.3% over the first nine months of the year
November 08, 2023 11:40 ET | NEURONES
PRESS INFORMATIONHeading: 3rd quarter 2023 revenues        Nanterre, November 8, 2023 (after trading) Organic growth up 12.3% over the first nine months of the year (not audited, in millions of...
NEURONES : + 12,3% d
NEURONES : + 12,3% de croissance organique en cumul à la fin du 3e trimestre 2023
November 08, 2023 11:40 ET | NEURONES
INFORMATION PRESSERubrique : C.A. 3e trimestre 2023        Nanterre, le 8 novembre 2023 (après Bourse) + 12,3% de croissance organique en cumul à la fin du 3e trimestre 2023 (non audités, en millions...
Logo.png
IHT FIRST FISCAL HALF REVENUES INCREASE
September 14, 2023 16:52 ET | InnSuites Hospitality Trust
Phoenix, AZ, Sept. 14, 2023 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) reported a continuation of improved results in the First Fiscal Half of 2024, (February 1, 2023, to...